Recombinant human nerve growth factor (Xintrum Pharmacouticals)

重组人神经生长因子（江苏中新医药）

Report date: 2025/10/21 17:57:21

Base Information

Drug NameRecombinant human nerve growth factor (Xintrum Pharmacouticals)
Drug Alias NameHuman nerve growth factor重组人神经生长因子注射液（江苏中新医药）rh-NGFZX1305ZX-1305 +[7] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionNeurons stimulantsNerve growth factor receptor Trk-A activatorsLow affinity neurotrophin receptor p75NTR agonists
TargetsLow affinity neurotrophin receptor p75NTRNerve growth factor receptor Trk-A
Therapy Area/IndicationsGlaucoma, Open-AngleKeratitisOptic Nerve Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJiangsu Zhongxin Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesJiangsu Zhongxin Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsGlaucoma, Open-AngleKeratitisOptic Nerve Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A